These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Matsumoto M; Ogawa W; Teshigawara K; Inoue H; Miyake K; Sakaue H; Kasuga M Diabetes; 2002 Jun; 51(6):1672-80. PubMed ID: 12031952 [TBL] [Abstract][Full Text] [Related]
43. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934 [TBL] [Abstract][Full Text] [Related]
44. Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression. Terai S; Aoki H; Ashida K; Thorgeirsson SS Hepatology; 2000 Aug; 32(2):357-66. PubMed ID: 10915743 [TBL] [Abstract][Full Text] [Related]
45. IRS proteins and the common path to diabetes. White MF Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E413-22. PubMed ID: 12169433 [TBL] [Abstract][Full Text] [Related]
46. [Obesity and inflammation]. Recasens M; Ricart W; Fernández-Real JM Rev Med Univ Navarra; 2004; 48(2):49-54. PubMed ID: 15382613 [TBL] [Abstract][Full Text] [Related]
47. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. Dubuquoy C; Robichon C; Lasnier F; Langlois C; Dugail I; Foufelle F; Girard J; Burnol AF; Postic C; Moldes M J Hepatol; 2011 Jul; 55(1):145-53. PubMed ID: 21145868 [TBL] [Abstract][Full Text] [Related]
49. [Knockout mouse models for type 2 diabetes. Mice with insulin resistance]. Terauchi Y; Kadowaki T Nihon Rinsho; 2002 Aug; 60 Suppl 8():64-9. PubMed ID: 12355825 [No Abstract] [Full Text] [Related]
50. Studies of the molecular genetics of impaired insulin secretion and obesity. Two intermediary phenotypes predisposing to type 2 diabetes mellitus. Urhammer S Dan Med Bull; 2001 May; 48(2):49-76. PubMed ID: 11414121 [No Abstract] [Full Text] [Related]
51. [Lifestyle to prevent cardiovascular disease in NIDDM]. Ezaki O Nihon Rinsho; 2006 Nov; 64(11):2083-8. PubMed ID: 17087300 [TBL] [Abstract][Full Text] [Related]
52. [Insulin therapy in diabetic patient with hypertension]. Hamaguchi T; Namba M Nihon Rinsho; 2003 Jul; 61(7):1238-44. PubMed ID: 12877091 [TBL] [Abstract][Full Text] [Related]
53. [Pathogenesis and etiology of cardiovascular disease: role of insulin resistance]. Takahashi A; Kushiro T Nihon Rinsho; 2006 Dec; 64 Suppl 9():163-8. PubMed ID: 17458212 [No Abstract] [Full Text] [Related]
54. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats. Park S; Hong SM; Sung SR Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751 [TBL] [Abstract][Full Text] [Related]
55. [Is hyperfattyacidemia related to the occurrence of diabetes?]. Oikawa S Nihon Rinsho; 2005 Feb; 63 Suppl 2():646-8. PubMed ID: 15779455 [No Abstract] [Full Text] [Related]